Concepts (290)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 19 | 2019 | 376 | 3.070 |
Why?
|
| Mammography | 12 | 2017 | 43 | 2.260 |
Why?
|
| Racism | 4 | 2022 | 36 | 1.890 |
Why?
|
| Kidney Failure, Chronic | 15 | 2021 | 158 | 1.830 |
Why?
|
| Early Detection of Cancer | 5 | 2018 | 89 | 1.830 |
Why?
|
| Healthcare Disparities | 7 | 2023 | 86 | 1.760 |
Why?
|
| Health Services Accessibility | 14 | 2021 | 109 | 1.730 |
Why?
|
| Health Status Disparities | 5 | 2020 | 74 | 1.610 |
Why?
|
| Renal Replacement Therapy | 9 | 2011 | 24 | 1.510 |
Why?
|
| Registries | 14 | 2011 | 201 | 1.470 |
Why?
|
| Kidney Transplantation | 6 | 2021 | 127 | 1.350 |
Why?
|
| Medically Uninsured | 2 | 2021 | 12 | 1.260 |
Why?
|
| Physicians | 2 | 2022 | 119 | 1.130 |
Why?
|
| Humans | 73 | 2023 | 30999 | 0.940 |
Why?
|
| Primary Health Care | 3 | 2021 | 100 | 0.910 |
Why?
|
| Practice Patterns, Physicians' | 5 | 2018 | 135 | 0.900 |
Why?
|
| Health Facilities | 1 | 2023 | 18 | 0.840 |
Why?
|
| Health Equity | 1 | 2023 | 19 | 0.830 |
Why?
|
| Chicago | 23 | 2019 | 943 | 0.810 |
Why?
|
| Academic Medical Centers | 2 | 2021 | 156 | 0.810 |
Why?
|
| Human Rights | 1 | 2022 | 3 | 0.800 |
Why?
|
| Middle Aged | 40 | 2021 | 10197 | 0.770 |
Why?
|
| Female | 53 | 2021 | 16985 | 0.770 |
Why?
|
| Referral and Consultation | 3 | 2021 | 91 | 0.770 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 159 | 0.750 |
Why?
|
| Community Health Services | 1 | 2021 | 31 | 0.750 |
Why?
|
| Ambulatory Care Facilities | 1 | 2021 | 39 | 0.750 |
Why?
|
| Dyslipidemias | 2 | 2018 | 23 | 0.730 |
Why?
|
| Health Personnel | 1 | 2022 | 117 | 0.730 |
Why?
|
| Socioeconomic Factors | 11 | 2020 | 335 | 0.720 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2018 | 66 | 0.700 |
Why?
|
| Adult | 36 | 2021 | 8933 | 0.700 |
Why?
|
| Emergency Service, Hospital | 4 | 2022 | 240 | 0.690 |
Why?
|
| Mass Screening | 10 | 2017 | 186 | 0.680 |
Why?
|
| Hospitalization | 2 | 2022 | 337 | 0.660 |
Why?
|
| Cancer Care Facilities | 1 | 2019 | 7 | 0.660 |
Why?
|
| Carcinoma, Ductal | 1 | 2019 | 5 | 0.660 |
Why?
|
| Cholesterol, LDL | 2 | 2018 | 33 | 0.630 |
Why?
|
| Renal Dialysis | 8 | 2021 | 109 | 0.620 |
Why?
|
| Violence | 1 | 2018 | 35 | 0.610 |
Why?
|
| Social Determinants of Health | 1 | 2018 | 32 | 0.610 |
Why?
|
| Cardiovascular Diseases | 3 | 2018 | 427 | 0.600 |
Why?
|
| Practice Guidelines as Topic | 7 | 2018 | 344 | 0.590 |
Why?
|
| Survival Rate | 6 | 2010 | 403 | 0.580 |
Why?
|
| Aged | 29 | 2021 | 10047 | 0.560 |
Why?
|
| Mortality | 5 | 2018 | 89 | 0.560 |
Why?
|
| Multicenter Studies as Topic | 3 | 2010 | 75 | 0.520 |
Why?
|
| Undocumented Immigrants | 1 | 2015 | 2 | 0.500 |
Why?
|
| Residence Characteristics | 5 | 2019 | 226 | 0.500 |
Why?
|
| Health Policy | 2 | 2015 | 54 | 0.500 |
Why?
|
| Value of Life | 1 | 2015 | 1 | 0.500 |
Why?
|
| Insurance Coverage | 1 | 2015 | 16 | 0.490 |
Why?
|
| Pregnancy Outcome | 3 | 2014 | 16 | 0.490 |
Why?
|
| United Kingdom | 10 | 2011 | 51 | 0.470 |
Why?
|
| Young Adult | 13 | 2021 | 2063 | 0.450 |
Why?
|
| Hospitals | 4 | 2022 | 165 | 0.430 |
Why?
|
| Waiting Lists | 2 | 2010 | 15 | 0.420 |
Why?
|
| Outpatient Clinics, Hospital | 4 | 2002 | 13 | 0.420 |
Why?
|
| Male | 29 | 2021 | 16447 | 0.420 |
Why?
|
| Cause of Death | 3 | 2010 | 67 | 0.410 |
Why?
|
| Community Health Planning | 2 | 2009 | 23 | 0.410 |
Why?
|
| United States | 10 | 2021 | 2375 | 0.400 |
Why?
|
| Tissue Donors | 2 | 2010 | 81 | 0.400 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2019 | 688 | 0.380 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 1009 | 0.380 |
Why?
|
| Peritoneal Dialysis | 1 | 2011 | 22 | 0.370 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2019 | 860 | 0.370 |
Why?
|
| Adolescent | 9 | 2021 | 2401 | 0.360 |
Why?
|
| National Health Programs | 2 | 2010 | 5 | 0.360 |
Why?
|
| Cesarean Section | 4 | 2014 | 30 | 0.360 |
Why?
|
| Retrospective Studies | 10 | 2021 | 3659 | 0.360 |
Why?
|
| Renal Insufficiency | 1 | 2010 | 14 | 0.350 |
Why?
|
| Hemoglobins | 3 | 2009 | 81 | 0.340 |
Why?
|
| Community Participation | 1 | 2009 | 16 | 0.330 |
Why?
|
| Risk Assessment | 7 | 2018 | 718 | 0.330 |
Why?
|
| Breech Presentation | 1 | 2008 | 3 | 0.320 |
Why?
|
| Version, Fetal | 1 | 2008 | 3 | 0.320 |
Why?
|
| Medical Audit | 1 | 2008 | 7 | 0.320 |
Why?
|
| ErbB Receptors | 1 | 2009 | 81 | 0.320 |
Why?
|
| Aged, 80 and over | 12 | 2018 | 5189 | 0.310 |
Why?
|
| Risk Factors | 9 | 2018 | 2588 | 0.310 |
Why?
|
| Incidence | 8 | 2019 | 785 | 0.300 |
Why?
|
| Pregnancy | 8 | 2020 | 403 | 0.300 |
Why?
|
| Smoking | 2 | 2005 | 197 | 0.290 |
Why?
|
| Hospitals, Public | 6 | 2002 | 31 | 0.280 |
Why?
|
| Annual Reports as Topic | 3 | 2010 | 3 | 0.270 |
Why?
|
| Guideline Adherence | 3 | 2018 | 68 | 0.260 |
Why?
|
| Intubation | 1 | 2005 | 7 | 0.260 |
Why?
|
| Heroin Dependence | 1 | 2005 | 9 | 0.260 |
Why?
|
| Public Health | 2 | 2017 | 68 | 0.260 |
Why?
|
| Cocaine-Related Disorders | 1 | 2005 | 17 | 0.260 |
Why?
|
| Extraction, Obstetrical | 2 | 1995 | 2 | 0.260 |
Why?
|
| Tobacco Use Disorder | 1 | 2005 | 17 | 0.250 |
Why?
|
| Smoking Cessation | 1 | 2005 | 47 | 0.240 |
Why?
|
| Geographic Information Systems | 1 | 2004 | 4 | 0.240 |
Why?
|
| Diabetes, Gestational | 2 | 2014 | 9 | 0.230 |
Why?
|
| New Zealand | 6 | 2019 | 13 | 0.220 |
Why?
|
| Age Factors | 6 | 2018 | 873 | 0.220 |
Why?
|
| Treatment Outcome | 5 | 2018 | 3807 | 0.220 |
Why?
|
| Health Status Indicators | 1 | 2004 | 78 | 0.220 |
Why?
|
| Time Factors | 6 | 2018 | 1672 | 0.220 |
Why?
|
| Cities | 3 | 2018 | 15 | 0.220 |
Why?
|
| Asthma | 1 | 2005 | 143 | 0.220 |
Why?
|
| Poverty | 5 | 2010 | 97 | 0.220 |
Why?
|
| Diabetes Mellitus | 2 | 2002 | 149 | 0.210 |
Why?
|
| Commerce | 1 | 2023 | 13 | 0.210 |
Why?
|
| Uterine Cervical Neoplasms | 5 | 1994 | 44 | 0.210 |
Why?
|
| Patient Transfer | 2 | 1996 | 21 | 0.210 |
Why?
|
| Uncompensated Care | 1 | 2002 | 2 | 0.200 |
Why?
|
| Databases, Factual | 3 | 2019 | 354 | 0.200 |
Why?
|
| Delivery, Obstetric | 2 | 2019 | 14 | 0.200 |
Why?
|
| Morbidity | 2 | 2001 | 64 | 0.200 |
Why?
|
| Health Priorities | 1 | 2001 | 5 | 0.200 |
Why?
|
| Public Health Administration | 1 | 2001 | 10 | 0.190 |
Why?
|
| Patient Compliance | 3 | 2018 | 158 | 0.190 |
Why?
|
| Social Class | 3 | 2010 | 70 | 0.190 |
Why?
|
| Aftercare | 1 | 2021 | 23 | 0.190 |
Why?
|
| Health Surveys | 3 | 2007 | 99 | 0.180 |
Why?
|
| Dystocia | 1 | 2020 | 1 | 0.180 |
Why?
|
| Research Design | 2 | 2020 | 219 | 0.180 |
Why?
|
| Income | 2 | 2005 | 80 | 0.170 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2011 | 80 | 0.170 |
Why?
|
| Sociology, Medical | 1 | 2019 | 3 | 0.170 |
Why?
|
| Hospitals, Urban | 2 | 1998 | 36 | 0.160 |
Why?
|
| Mortality, Premature | 1 | 2018 | 6 | 0.160 |
Why?
|
| Illinois | 4 | 2015 | 267 | 0.160 |
Why?
|
| Survival Analysis | 2 | 2009 | 320 | 0.160 |
Why?
|
| Infant, Low Birth Weight | 1 | 2018 | 16 | 0.160 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 18 | 0.150 |
Why?
|
| General Practice | 1 | 2018 | 2 | 0.150 |
Why?
|
| Global Health | 1 | 2018 | 58 | 0.150 |
Why?
|
| Quality of Health Care | 4 | 2020 | 146 | 0.150 |
Why?
|
| England | 4 | 2011 | 13 | 0.150 |
Why?
|
| Infant, Newborn | 5 | 2019 | 637 | 0.150 |
Why?
|
| Germany | 1 | 2017 | 9 | 0.150 |
Why?
|
| Cholesterol | 1 | 2018 | 54 | 0.150 |
Why?
|
| Prevalence | 5 | 2014 | 499 | 0.150 |
Why?
|
| Medical Overuse | 1 | 2017 | 7 | 0.150 |
Why?
|
| Down-Regulation | 1 | 2017 | 113 | 0.140 |
Why?
|
| Biomarkers | 2 | 2018 | 733 | 0.140 |
Why?
|
| Women's Health | 2 | 2017 | 242 | 0.140 |
Why?
|
| False Negative Reactions | 1 | 2016 | 15 | 0.140 |
Why?
|
| Health Education | 3 | 1994 | 42 | 0.140 |
Why?
|
| Facility Regulation and Control | 1 | 1996 | 2 | 0.140 |
Why?
|
| Quality Control | 1 | 2016 | 47 | 0.140 |
Why?
|
| Neoplasm Staging | 3 | 2018 | 404 | 0.140 |
Why?
|
| Urban Health | 3 | 2004 | 24 | 0.140 |
Why?
|
| Epidemiologic Methods | 2 | 2015 | 20 | 0.140 |
Why?
|
| Observer Variation | 1 | 2016 | 118 | 0.130 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 216 | 0.130 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 583 | 0.130 |
Why?
|
| Quality Assurance, Health Care | 1 | 2016 | 50 | 0.130 |
Why?
|
| Urban Population | 5 | 2005 | 148 | 0.130 |
Why?
|
| Emergency Medical Services | 1 | 1996 | 36 | 0.130 |
Why?
|
| Comorbidity | 1 | 2017 | 507 | 0.130 |
Why?
|
| Wales | 3 | 2010 | 4 | 0.130 |
Why?
|
| Civil Defense | 1 | 2015 | 7 | 0.130 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2015 | 8 | 0.130 |
Why?
|
| Quality Indicators, Health Care | 1 | 2016 | 42 | 0.130 |
Why?
|
| Financing, Government | 1 | 2015 | 15 | 0.130 |
Why?
|
| Reimbursement Mechanisms | 1 | 2015 | 14 | 0.120 |
Why?
|
| Patient Safety | 1 | 2016 | 53 | 0.120 |
Why?
|
| Hospitals, Maternity | 1 | 1995 | 3 | 0.120 |
Why?
|
| Stereotyping | 1 | 2015 | 8 | 0.120 |
Why?
|
| Schools, Medical | 1 | 2015 | 21 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 1998 | 310 | 0.120 |
Why?
|
| Birth Weight | 1 | 2014 | 35 | 0.120 |
Why?
|
| Faculty, Medical | 1 | 2015 | 38 | 0.120 |
Why?
|
| Students, Medical | 1 | 2015 | 49 | 0.120 |
Why?
|
| Neoplasms | 1 | 2017 | 260 | 0.120 |
Why?
|
| Syphilis | 1 | 1994 | 4 | 0.120 |
Why?
|
| HIV Seroprevalence | 1 | 1994 | 4 | 0.120 |
Why?
|
| Prognosis | 3 | 2012 | 918 | 0.120 |
Why?
|
| Sexually Transmitted Diseases | 1 | 1994 | 18 | 0.110 |
Why?
|
| Community Health Nursing | 1 | 1994 | 12 | 0.110 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 818 | 0.110 |
Why?
|
| Postpartum Period | 1 | 1993 | 26 | 0.110 |
Why?
|
| Cohort Studies | 5 | 2019 | 2042 | 0.100 |
Why?
|
| Lymphatic Metastasis | 1 | 2012 | 104 | 0.100 |
Why?
|
| Hemodialysis, Home | 1 | 2011 | 1 | 0.090 |
Why?
|
| Disasters | 1 | 2011 | 3 | 0.090 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 1 | 2011 | 13 | 0.090 |
Why?
|
| Tetanus | 1 | 2011 | 10 | 0.090 |
Why?
|
| Developing Countries | 1 | 2011 | 21 | 0.090 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2010 | 19 | 0.090 |
Why?
|
| Models, Theoretical | 1 | 2010 | 94 | 0.090 |
Why?
|
| Hemodialysis Units, Hospital | 1 | 2009 | 1 | 0.080 |
Why?
|
| Living Donors | 1 | 2009 | 7 | 0.080 |
Why?
|
| Patient Selection | 2 | 2011 | 246 | 0.080 |
Why?
|
| Advisory Committees | 1 | 2009 | 34 | 0.080 |
Why?
|
| Health Services Research | 3 | 2002 | 41 | 0.080 |
Why?
|
| Prospective Studies | 4 | 2009 | 1898 | 0.080 |
Why?
|
| Counseling | 1 | 2008 | 49 | 0.080 |
Why?
|
| Odds Ratio | 1 | 2009 | 291 | 0.080 |
Why?
|
| Logistic Models | 1 | 2009 | 409 | 0.080 |
Why?
|
| Europe | 3 | 2010 | 79 | 0.080 |
Why?
|
| Interviews as Topic | 2 | 2002 | 132 | 0.080 |
Why?
|
| Follow-Up Studies | 4 | 2018 | 1923 | 0.070 |
Why?
|
| Mexico | 1 | 2007 | 17 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 549 | 0.070 |
Why?
|
| HIV Infections | 1 | 1994 | 890 | 0.070 |
Why?
|
| Early Diagnosis | 1 | 2007 | 69 | 0.070 |
Why?
|
| Unemployment | 1 | 2005 | 2 | 0.060 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 2004 | 2 | 0.060 |
Why?
|
| Anemia, Sickle Cell | 1 | 2004 | 13 | 0.060 |
Why?
|
| Infant | 2 | 2009 | 578 | 0.060 |
Why?
|
| Acute Disease | 1 | 2005 | 231 | 0.060 |
Why?
|
| Chest Pain | 1 | 2004 | 24 | 0.060 |
Why?
|
| Reoperation | 1 | 2009 | 950 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2009 | 689 | 0.060 |
Why?
|
| Glucose Tolerance Test | 2 | 2014 | 12 | 0.060 |
Why?
|
| Attitude to Health | 3 | 2011 | 100 | 0.060 |
Why?
|
| Lung | 1 | 2004 | 173 | 0.060 |
Why?
|
| Educational Status | 1 | 2005 | 312 | 0.060 |
Why?
|
| Disease Outbreaks | 2 | 2011 | 93 | 0.050 |
Why?
|
| Critical Care | 1 | 2005 | 246 | 0.050 |
Why?
|
| Intensive Care Units | 1 | 2005 | 328 | 0.050 |
Why?
|
| Disease Progression | 1 | 2005 | 830 | 0.050 |
Why?
|
| Child | 2 | 2009 | 1430 | 0.050 |
Why?
|
| Policy | 1 | 2021 | 11 | 0.050 |
Why?
|
| Poverty Areas | 1 | 2001 | 10 | 0.050 |
Why?
|
| Health Care Surveys | 2 | 1998 | 68 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2009 | 300 | 0.050 |
Why?
|
| Medicare | 1 | 2021 | 127 | 0.050 |
Why?
|
| Aging | 1 | 2010 | 1727 | 0.050 |
Why?
|
| Parathyroid Hormone | 2 | 2010 | 23 | 0.040 |
Why?
|
| Axilla | 1 | 2019 | 15 | 0.040 |
Why?
|
| Traction | 1 | 2019 | 30 | 0.040 |
Why?
|
| Life Expectancy | 1 | 2018 | 22 | 0.040 |
Why?
|
| Ontario | 1 | 2018 | 19 | 0.040 |
Why?
|
| Medical Indigency | 1 | 1998 | 1 | 0.040 |
Why?
|
| North America | 1 | 2018 | 39 | 0.040 |
Why?
|
| Italy | 1 | 2018 | 15 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2018 | 99 | 0.040 |
Why?
|
| Geography | 1 | 2018 | 22 | 0.040 |
Why?
|
| Hospital Charges | 1 | 1998 | 20 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2018 | 123 | 0.040 |
Why?
|
| Community Health Centers | 3 | 1993 | 12 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 662 | 0.030 |
Why?
|
| Pacific Islands | 1 | 1995 | 2 | 0.030 |
Why?
|
| Analgesia, Obstetrical | 1 | 1995 | 27 | 0.030 |
Why?
|
| Analgesia, Epidural | 1 | 1995 | 59 | 0.030 |
Why?
|
| Organizational Policy | 1 | 1995 | 16 | 0.030 |
Why?
|
| Fetal Macrosomia | 1 | 2014 | 1 | 0.030 |
Why?
|
| Labor, Induced | 1 | 2014 | 3 | 0.030 |
Why?
|
| Fasting | 1 | 2014 | 13 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 52 | 0.030 |
Why?
|
| Health Resources | 1 | 2014 | 24 | 0.030 |
Why?
|
| Seroepidemiologic Studies | 1 | 1994 | 19 | 0.030 |
Why?
|
| Fetal Death | 1 | 1993 | 6 | 0.030 |
Why?
|
| Demography | 2 | 2011 | 81 | 0.030 |
Why?
|
| Medical Records | 1 | 1993 | 34 | 0.030 |
Why?
|
| Program Evaluation | 1 | 1994 | 136 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 1994 | 190 | 0.020 |
Why?
|
| New York City | 1 | 2011 | 17 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2011 | 49 | 0.020 |
Why?
|
| Clostridium tetani | 1 | 2011 | 3 | 0.020 |
Why?
|
| Tetanus Toxoid | 1 | 2011 | 10 | 0.020 |
Why?
|
| Endemic Diseases | 1 | 2011 | 8 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2011 | 20 | 0.020 |
Why?
|
| Metronidazole | 1 | 2011 | 9 | 0.020 |
Why?
|
| Wounds, Penetrating | 1 | 2011 | 11 | 0.020 |
Why?
|
| Vaccination | 1 | 2011 | 48 | 0.020 |
Why?
|
| Phosphates | 1 | 2010 | 20 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2011 | 63 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2009 | 24 | 0.020 |
Why?
|
| Asia | 1 | 2009 | 10 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 368 | 0.020 |
Why?
|
| Risk | 1 | 2009 | 222 | 0.020 |
Why?
|
| Papanicolaou Test | 3 | 1993 | 9 | 0.020 |
Why?
|
| Vaginal Smears | 3 | 1993 | 15 | 0.020 |
Why?
|
| Ethics, Institutional | 1 | 1987 | 1 | 0.020 |
Why?
|
| Insurance, Hospitalization | 1 | 1987 | 2 | 0.020 |
Why?
|
| Government Regulation | 1 | 1987 | 6 | 0.020 |
Why?
|
| Federal Government | 1 | 1987 | 4 | 0.020 |
Why?
|
| Vulnerable Populations | 1 | 1987 | 25 | 0.020 |
Why?
|
| Calcium | 1 | 2010 | 502 | 0.020 |
Why?
|
| Transfer Agreement | 1 | 1986 | 1 | 0.020 |
Why?
|
| Patient Admission | 1 | 1986 | 30 | 0.020 |
Why?
|
| Blood Cell Count | 1 | 2004 | 17 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2004 | 29 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2005 | 148 | 0.020 |
Why?
|
| Physical Examination | 2 | 1993 | 118 | 0.010 |
Why?
|
| Health Services | 1 | 1998 | 9 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1998 | 324 | 0.010 |
Why?
|
| Computers | 1 | 1976 | 27 | 0.010 |
Why?
|
| Appointments and Schedules | 1 | 1993 | 14 | 0.010 |
Why?
|
| Data Collection | 1 | 1993 | 109 | 0.010 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1986 | 8 | 0.000 |
Why?
|
| Time | 1 | 1986 | 17 | 0.000 |
Why?
|